Alkermes Plc (ALKS)

Alkermes Plc (ALKS) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.4B; returns 1 day -1.2%, 1 week +5.8%, 1 year +45.2%.

Alkermes Plc is a fully integrated biopharmaceutical company primarily focused on developing and commercializing innovative medicines for serious central nervous system (CNS) disorders.

Groups ALKS belongs to

• Shrinking Share Count
• Biopharmaceutical
• Neuroscience
• CNS Disorders
• Healthcare
• Pharmaceuticals
• Commercial Stage
• Commercial Stage Biotech
• Long-Acting Injectables
• Neurological Disorders
• Biotechnology

ALKS financial model: income statement, cash flow and balance sheet